Anal cancers attributed to human papillomavirus are more common in areas in Victoria, Australia, with higher HIV notifications
Lenka A Vodstrcil, Jane Hocking, Tim RH Read, Andrew E Grulich, Christopher K Fairley
Sexual Health | CSIRO PUBLISHING | Published : 2013
CKF owns shares in CSL Biotherapies, the manufacturer for Gardasil. CKF and AG have received honoraria from CSL Biotherapies and Merck. AG and CKF also receive research funding from CSL Biotherapies.